CMS Open Payments · Program Year 2024
Rayner Intraocular Lenses Limited
Rayner Intraocular Lenses Limited reported $421,731.65 across General Payments, Research, and Ownership to 2,145 physicians and teaching hospitals across 2,162 transactions.
- $421.7K Above-median payer
- All-tracks total
- 2,162 Top quartile volume
- Transactions
- 2,145 Top quartile reach
- Recipients
- +$26.3K
- General Payments vs PY2023
Rayner Intraocular Lenses Limited reported $421,731.65 across all CMS Open Payments tracks (General + Research + Ownership) to 2,145 physicians and teaching hospitals in Program Year 2024 - ranking #805 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $262,704.15, averaging $196.61 per recipient.
How Rayner Intraocular Lenses Limited's $421.7K all-tracks total breaks down
Rayner Intraocular Lenses Limited's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
32/100
Total payments
F
14/100
Transaction volume
F
26/100
Physician reach
F
26/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer rayner-intraocular-lenses-limited Rayner Intraocular Lenses Limited
$421.7K · #805/1,925 · 0.0% industry · PY2024
- TOT $421.7K
- RANK #805
- SHARE 0.0%
- TXN 2,162
- RCP 2,145
- CAT 5
- GEN $262.7K
- ΔGEN +$26.3K
- TOP1 26.4%
- PY 2024
Volume peers
Nearest volume peer: Almatica Pharma LLC ($421.9K)
Rayner Intraocular Lenses Limited sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Rayner Intraocular Lenses Limited's CMS-reported General Payments increased by $26.3K (+11.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: RAYNER INTRAOCULAR LENSES LIMITEDPY2023: RAYNER INTRAOCULAR LENSES LIMITEDPY2024: Rayner Intraocular Lenses Limited. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $236,367.25
- PY2024
- $262,704.15
What the Data Shows for Rayner Intraocular Lenses Limited
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Rayner Intraocular Lenses Limited, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 5 general-payment categories charted below, "Consulting Fee" is the largest at $98.1K across 29 transactions, 37.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 5 types of general payments, Rayner Intraocular Lenses Limited's largest category was "Consulting Fee" at $98.1K - 37.3% of General Payments.
Rayner Intraocular Lenses Limited reports 5 general-payment categories - the top three are Consulting Fee (37.3%), Compensation for Services Other Than Consulting (34.6%), and Food and Beverage (23.1%). The remaining 2 categories make up 4.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Rayner Intraocular Lenses Limited divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $98.1K | 29 | 37.3% |
| Compensation for Services Other Than Consulting | $90.9K | 19 | 34.6% |
| Food and Beverage | $60.7K | 2,077 | 23.1% |
| Grant | $7.5K | 1 | 2.9% |
| Travel and Lodging | $5.4K | 19 | 2.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $140,121.05 (53.3%) of $262,704.15 in this company's General Payments records across 1,437 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Rayner Intraocular Lenses Limited
The five named recipients with the highest reported General Payments from this company
- 1
Brett Bielory
$69,243.94 across 38 reported transactions
- 2
David Goldman
$26,362.83 across 15 reported transactions
- 3
Sara Butterworth
$18,462.50 across 2 reported transactions
- 4
Rajen U Desai
$13,329.25 across 6 reported transactions
- 5
Michael Alterman
$12,722.53 across 8 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Rayner Intraocular Lenses Limited's spend rank (#805 of 1,925, top 42% by spend) and concentration rank (#1,050 of 1,838, bottom 43% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Ge Healthcare : $6.4M total payments, HHI 966
- Occlutech US LLC : $1.2M total payments, HHI 961
- Cytyc Surgical Products, LLC : $12.4K total payments, HHI 961
- BioXcel Therapeutics, Inc. : $116.0K total payments, HHI 958
- Spinefrontier, Inc. : $26.7K total payments, HHI 958
- PARI Respiratory Equipment, Inc. : $262.70 total payments, HHI 954
- Rayner Intraocular Lenses Limited (this company) : $262.7K total payments, HHI 950
- STRATA Skin Sciences, Inc. : $89.3K total payments, HHI 940
- Neptune Medical Inc. : $119.4K total payments, HHI 936
- Spirair, Inc. : $58.8K total payments, HHI 936
- Neoss, Inc. : $107.6K total payments, HHI 934
- Acist Medical Systems, Inc. : $163.3K total payments, HHI 931
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Rayner Intraocular Lenses Limited's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Rayner Intraocular Lenses Limited.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Rayner Intraocular Lenses Limited.
Showing 6 of 1,924 companies with CMS-reported payment data.
Bio-Rad Laboratories, Inc.
CeQur Corporation
Cepheid
WyCo Surgical Distribution LLC
Incline Medical
Put this to use
Rayner Intraocular Lenses Limited ranks #805 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Rayner Intraocular Lenses Limited. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.